Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Atherosclerosis

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2015.06.059PMID 26188532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early atherosclerosis in HIV-infected patients below the age of 55 years: Slovenian national study

  2014cited by this paper
• High-Fat Meals Do Not Impair Postprandial Endothelial Function in HIV-Infected and Uninfected Men

  2014cited by this paper
• HIV is an independent predictor of aortic stiffness

  2014cited by this paper
• Antiretroviral Therapy-Induced Mitochondrial Toxicity: Potential Mechanisms Beyond Polymerase-γ Inhibition

  2014cited by this paper
• Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities.

  2014cited by this paper
• Cardiometabolic markers to identify cardiovascular disease risk in HIV-infected black South Africans.

  2014cited by this paper
• Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients

  2014cited by this paper
• Inflammation Markers Correlate With Common Carotid Intima‐Media Thickness in Patients Perinatally Infected With Human Immunodeficiency Virus 1

  2013cited by this paper
• The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study.

  2013cited by this paper
• The Evaluation of Carotid Atherosclerosis in Patients with the HIV-1 Infection: The Role of the Antiretroviral Therapy.

  2013cited by this paper
• Silent Ischemic Heart Disease and Pericardial Fat Volume in HIV-Infected Patients: A Case-Control Myocardial Perfusion Scintigraphy Study

  2013cited by this paper
• Effects of antiretroviral therapy on arterial stiffness in Cameroonian HIV-infected patients

  2013cited by this paper
• Endothelial dysfunction, increased inflammation, and activated coagulation in HIV‐infected patients improve after initiation of highly active antiretroviral therapy

  2013cited by this paper
• Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy

  2013cited by this paper
• HIV and the heart: the impact of antiretroviral therapy: a global perspective.

  2013cited by this paper
• Effects of aging and smoking on carotid intima–media thickness in HIV-infection

  2013cited by this paper
• Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon

  2013cited by this paper
• Metabolic Syndrome in Human Immunodeficiency Virus–Positive Subjects: Prevalence, Phenotype, and Related Alterations in Arterial Structure and Function

  2013cited by this paper
• Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS).

  2013cited by this paper
• Progression of Carotid Intima-Media Thickness and Coronary Artery Calcium Over 6 Years in an HIV-Infected Cohort

  2013cited by this paper
• Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?

  2012cited by this paper
• Impaired distensibility of ascending aorta in patients with HIV infection

  2012cited by this paper
• Short Communication High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor Cells

  2012cited by this paper
• Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study.

  2012cited by this paper
• Protease inhibitor treatment effect on aortic stiffness in normotensive patients with human immunodeficiency virus infection.

  2012cited by this paper
• Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.

  2012cited by this paper
• Low free testosterone in HIV‐infected men is not associated with subclinical cardiovascular disease

  2012cited by this paper
• Ultrasonography in lesions of the carotid vessels in HIV positive patients Valutazione ecografica delle lesioni vascolari carotidee nei pazienti HIV positivi

  2011cited by this paper
• Gp120 activates children’s brain endothelial cells via CD4

  2011cited by this paper
• Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women

  2011cited by this paper
• Ultrasonography in lesions of the carotid vessels in HIV positive patients

  2011cited by this paper
• Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?

  2011cited by this paper
• Arterial stiffness and carotid intima-media thickness in HIV infected patients.

  2011cited by this paper
• Cardiovascular implications of HIV-induced dyslipidemia.

  2011cited by this paper
• Relationship of Body Composition, Metabolic Status, Antiretroviral Use, and HIV Disease Factors to Endothelial Dysfunction in HIV-Infected Subjects

  2010cited by this paper
• Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults.

  2010cited by this paper
• TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure.

  2010cited by this paper
• HIV infection: an independent risk factor of peripheral arterial disease.

  2010cited by this paper
• Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors.

  2009cited by this paper
• Increased Arterial Stiffness in HIV-Infected Children: Risk Factors and Antiretroviral Therapy

  2009cited by this paper
• Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy

  2009cited by this paper
• Association of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus.

  2009cited by this paper
• Human immunodeficiency virus per se exerts atherogenic effects.

  2009cited by this paper
• Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study

  2009cited by this paper
• Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men

  2009cited by this paper
• Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection

  2009cited by this paper
• HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies

  2009cited by this paper
• Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

  2009cited by this paper
• Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.

  2008cited by this paper
• Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapy

  2008cited by this paper
• Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia

  2008cited by this paper
• Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.

  2008cited by this paper
• The Relationship Between HIV Infection and Cardiovascular Disease

  2008cited by this paper
• HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease.

  2008cited by this paper
• Cross-Sectional Study of Endothelial Function in HIV-Infected Patients in Brazil

  2008cited by this paper
• Aortic Stiffness in Untreated Adult Patients With Human Immunodeficiency Virus Infection

  2008cited by this paper
• Carotid intima–media thickness in HIV patients treated with antiretroviral therapy

  2007cited by this paper
• Carotid Intima-Media Thickness in HIV-Infected Individuals: Relationship of Premature Atherosclerosis to Neuropsychological Deficits?

  2006cited by this paper
• Endothelial function in HIV-infected persons.

  2006cited by this paper
• Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients.

  2006cited by this paper
• Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis.

  2006cited by this paper
• Endothelial function in HIV-infected patients with low or mild cardiovascular risk.

  2006cited by this paper
• Impact of Treatment With Protease Inhibitors on Aortic Stiffness in Adult Patients With Human Immunodeficiency Virus Infection

  2005cited by this paper
• Early Structural and Functional Changes of the Vasculature in HIV-Infected Children: Impact of Disease and Antiretroviral Therapy

  2005cited by this paper
• Arterial stiffness and endothelial dysfunction in HIV-infected children

  2004cited by this paper
• Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?

  2003cited by this paper
• Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.

  2003cited by this paper
• Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement

  2002cited by this paper
• Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation.

  2002cited by this paper
• Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors.

  2002cited by this paper
• HIV preferentially infects HIV-specific CD4+ T cells

  2002cited by this paper
• Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial Dysfunction

  2001cited by this paper
• HIV envelope gp120 activates human arterial smooth muscle cells

  2001cited by this paper
• Mitochondrial involvement in antiretroviral therapy-related lipodystrophy

  2001cited by this paper
• HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis

  2000cited by this paper
• Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis.

  1998cited by this paper
• Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor.

  1997cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• FAST TRACK: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome

  year unknowncited by this paper

• Agreement and Fairness of Cardiovascular Risk Assessment Models Among Older People Living With HIV in China: A Multicenter Cross-sectional Study.

  2026cites this paper
• Risk Factors for Major Adverse Cardiovascular Events in Antiretroviral Therapy-Treated People with HIV: A Long-Term Cohort Study in Turkey

  2025cites this paper
• Cardiovascular Risk in People Living with Human Immunodeficiency (HIV) Viremia Suppression in a Young, Mid-Eastern European Population - Preliminary Study

  2024cites this paper
• Lack of impact of HIV status on carotid intima media thickness in a cohort of stroke patients in South Africa.

  2024cites this paper
• Incidence and risk factors of hypertriglyceridemia in males with human immunodeficiency virus who are treated with combination antiretroviral therapy: a retrospective cohort study

  2023cites this paper
• Assessment of Cardiovascular Risk and Arterial Stiffness in Patients With Human Immunodeficiency Virus

  2023cites this paper
• Associative Prediction of Carotid Artery Plaques Based on Ultrasound Strain Imaging and Cardiovascular Risk Factors in People Living With HIV and Age-Matched Control Subjects of the CHACS Cohort

  2022cites this paper
• The Relationship Between Cancer and Functional and Structural Markers of Subclinical Atherosclerosis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Cytomegalovirus may influence vascular endothelial health in Indonesian HIV-infected patients after 5 years on ART

  2021cites this paper
• Cardiovascular risk and stroke mortality in persons living with HIV: a longitudinal study in a hospital in Yaounde

  2021cites this paper
• The Power and Wisdom of Prevention. Cardiovascular Risk, New Challenge and Approach to PLWH

  2021cites this paper
• Cardiovascular risks in Asian HIV-infected patients receiving boosted-protease inhibitor-based antiretroviral treatment.

  2021cites this paper
• Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV

  2021cites this paper
• HIV and cardiovascular disease.

  2020cites this paper
• The Effectiveness of Protease Inhibitors in the Campaign against HIV/AIDS:A Closer Look at the Critical Factors of ART Compliance and Survival

  2020cites this paper
• Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome.

  2020cites this paper
• The Search for the Most Efficacious Engagement Point in theCampaign against HIV: A Closer Look at the Life Cycle of theHuman Immunodeficiency Virus

  2020cites this paper
• Aortic Stiffness in HIV Infection with and without Antiretroviral Therapy. A Meta-analysis of Observational Studies

  2020influential citation
• Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.

  2020cites this paper
• Deciphering Endothelial Dysfunction in the HIV-Infected Population.

  2019cites this paper
• Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients.

  2019cites this paper
• The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis.

  2019cites this paper
• No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up

  2019influential citation
• Progressione dell’aterosclerosi subclinica nei pazienti HIV-positivi naïve che iniziano una terapia antiretrovirale comprendente un inibitore dell’integrasi.

  2019cites this paper
• HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers

  2018cites this paper
• Paramètres hémodynamiques artériels et risque cardiovasculaire chez les patients vivant avec le VIH et en succès immuno-virologique

  2018cites this paper
• The relationship of depressive symptoms and functional and structural markers of subclinical atherosclerosis: A systematic review and meta-analysis

  2018cites this paper
• [Arterial hemodynamic parameters and cardiovascular risk in HIV patients with controlled infection].

  2018cites this paper
• Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen

  2018cites this paper
• Cardiovascular disease burden among human immunodeficiency virus-infected individuals.

  2018cites this paper
• Carotid Artery Stiffness and Cognitive Decline Among Women With or at Risk for HIV Infection

  2018cites this paper
• Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection

  2018cites this paper
• Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study

  2018cites this paper
• Cardiovascular risk and dyslipidemia among persons living with HIV: a review

  2017cites this paper
• Arterial stiffness in HIV-infected youth and associations with HIV-related variables

  2017cites this paper
• Cardiovascular disease in women with HIV-1 infection.

  2017cites this paper
• Aortic stiffness aging is influenced by past profound immunodeficiency in HIV-infected individuals: results from the EVAS-HIV (EValuation of Aortic Stiffness in HIV-infected individuals)

  2016cites this paper
• The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds

  2016cites this paper
• Inflammatory Cytokines, Endothelial Function, and Chronic Allograft Vasculopathy in Children: An Investigation of the Donor and Recipient Vasculature After Heart Transplantation

  2016cites this paper
• Complications of Treatment in Youth with HIV

  2016cites this paper
• Cardiovascular Complications of Human Immunodeficiency Virus Infection HIV and Cardiovascular Disease

  year unknowncites this paper